Boston Scientific’s Cardiac Portfolio Powers Upward Financial Revision Amid Industry Momentum
Strong Cardiac Device Performance Drives Optimistic Outlook Boston Scientific has elevated its full-year profit guidance following impressive third-quarter results that…
